Skip to main content
LUSHANG FREDA PHARMACEUTICAL CO.,LTD. logo

LUSHANG FREDA PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 600223 ISIN · CNE000001147 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,828 across all filing types
Latest filing 2025-08-21 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600223

About LUSHANG FREDA PHARMACEUTICAL CO.,LTD.

http://www.lshfreda.com/

Lushang Freda Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, health supplements, and high-end cosmetics. The company is recognized as a global leader in the production of sodium hyaluronate (hyaluronic acid), utilizing advanced fermentation technology to supply raw materials for medical, food, and cosmetic applications. Its product portfolio spans several therapeutic areas, including ophthalmology, orthopedics, and dermatology, with a significant focus on medical aesthetics and functional skincare. By integrating biotechnology with industrial-scale production, the company maintains a comprehensive supply chain that supports both its proprietary brands and international B2B partnerships. Key operations involve the synthesis of bioactive substances and the formulation of specialized treatments designed to improve skin health and joint mobility.

Recent filings

Filing Released Lang Actions
鲁商福瑞达医药股份有限公司关于聘任公司董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new company secretary for the board of directors. It includes details about the individual's qualifications, compliance with regulatory requirements, and contact information. There is no financial data, no mention of financial results, no voting results, no legal proceedings, or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-08-21 Chinese
鲁商福瑞达医药股份有限公司全面预算管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management policy titled '全面预算管理制度' (Comprehensive Budget Management System) issued by 鲁商福瑞达医药股份有限公司. It outlines the company's budget management principles, organizational structure, budgeting process, execution, control, adjustment, and assessment. There is no indication that this is a financial report, audit, earnings release, or any regulatory filing. It is a governance-related document detailing internal rules and procedures related to budgeting and financial management within the company. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is the full policy, not an announcement or summary.
2025-08-21 Chinese
鲁商福瑞达医药股份有限公司内幕信息知情人管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for insider information at 鲁商福瑞达医药股份有限公司. It outlines the rules, responsibilities, and procedures related to insider information management, including definitions, scope, insider personnel, confidentiality, and legal responsibilities. It references relevant laws and regulatory requirements but does not contain financial statements, earnings data, or any form of financial reporting. It is a governance-related document focused on compliance and internal controls regarding insider information. Therefore, it fits best under Governance Information (CGR). The document length (5884 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive governance policy document.
2025-08-21 Chinese
鲁商福瑞达医药股份有限公司信息披露管理制度
Governance Information Classification · 95% confidence The document is a comprehensive information disclosure management system of a company, detailing the rules, responsibilities, procedures, and legal compliance related to information disclosure. It includes sections on periodic reports (annual, interim, quarterly), temporary reports, confidentiality, insider information, internal controls, and responsibilities of directors and management. It does not contain actual financial statements or financial results but rather the governance and procedural framework for disclosures. This type of document fits best under Governance Information (CGR), as it details the company's internal rules and governance practices related to information disclosure.
2025-08-21 Chinese
鲁商福瑞达医药股份有限公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 鲁商福瑞达医药股份有限公司, dated August 2025. It contains detailed provisions about the company's organization, shareholder rights, board structure, management, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication of financial statements, audit opinions, earnings data, or meeting results. The content is a governance document outlining the internal rules and regulations of the company. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2025-08-21 Chinese
鲁商福瑞达医药股份有限公司2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by 鲁商福瑞达医药股份有限公司. It details the dividend distribution per share, relevant dates for dividend payment, tax withholding policies, and shareholder meeting approval date. The content focuses on the announcement of dividend amounts, payment dates, and related procedures. It does not contain full financial statements or comprehensive financial performance data. The document length is relatively short (2346 characters) and is clearly an announcement of dividend distribution rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-07-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.